Institutional Access, Deep Research & Advanced Investor insights.
OTC Stock Lookup
Fintech / Prediction Markets
The CEO of Winners Inc. (OTC: WNRS) on the Reg A+ raise, the MeVu prediction market aggregator, AI agent swarms, and the path to OTCQX uplisting.
On the Reg A+ raise, the MeVu prediction market aggregator, AI agent swarms, and the path to OTCQX uplisting.
Showing 5 of 200+ interviews
Browse all interviews →Management is evolving WNRS beyond traditional gaming into prediction market infrastructure — AI-Powered Prediction Markets, Strategic Acquisitions, Uplisting Potential.
NexTel Medical is transitioning from a developmental biotech story into a revenue-generating healthcare platform with $135K–$140K in monthly recurring revenue already established.
IR Programs
Proven guidance. Trusted expertise. Stronger future. Our network connects OTC issuers with the institutional relationships, capital markets intelligence, and strategic visibility needed to uplift to a major exchange.
The OTC Leads interview with Vantage Micro Capital's CEO changed how I think about small-cap allocation entirely.
I've been in capital markets for 20 years. The access OTC Leads provides to management teams is genuinely rare.
My clients ask where I get my OTC research. I tell them it's proprietary. It's OTC Leads.
Membership
Membership is selective — we vet every applicant to ensure signal, not noise. Applications are reviewed within 48 hours.
